Prostate Cancer

Our nationally and internationally known specialists offer the most up-to-date, research-backed prostate cancer treatments, including targeted ablation using cryo-ablation and high-intensity focused ultrasound, or HIFU. Our comprehensive services include precision screening, diagnosis, post-treatment rehabilitation, and integrative therapies, as well as second opinion consultations to help you better understand your testing and treatment options.

Perlmutter Cancer Center doctors share in the growing consensus among top prostate cancer specialists that many men are being overtreated for prostate cancer. We work together to identify which men are best served by aggressive treatment and those who can be treated safely with a more conservative approach. We believe in empowering you with information, so that you can actively partner in creating a personalized treatment plan that’s right for you.

Clinical Trials and Research Studies

Phase 3

DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomised phase 3 double-blind placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high risk clinically localised prostate cancer

Learn More

Phase 5

A Phase 1 and 2a trial of LAVA-1207 in patients with therapy refractory metastatic castration resistant prostate cancer

Learn More

Phase 5

10301 - A Phase I and Randomized Phase II Trial of Radium-223 dichloride M3814 & Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Learn More

Phase 3

PSMAfore: A phase III Open-label Multi-Center Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of androgen receptor-directed therapy in the Treatment of Taxane Na ve Men with Progressive Metastatic Castrate Resistant Prostate Cancer

Learn More